GLP-1 Medication Comparison: Ozempic vs Wegovy vs Mounjaro vs Zepbound
A side-by-side comparison of the major GLP-1 medications: molecule, dosing, cost, FDA indication, side effects, and average weight loss. Pick the right one for your situation.
GLP-1 medications are not willpower dieting. They kill appetite — and that is both the benefit and the danger. Under-eat protein on these drugs and you lose muscle, slow your metabolism, and rebound the moment you stop. Sharpy is built around one question:
When the medication stops, what will you have left?
Six features designed around how GLP-1s actually feel — appetite suppression, muscle risk, and the maintenance phase nobody plans for.
Plans designed around appetite-suppressing side-effects: nausea, early fullness, food aversion. Real food, portioned for your dose and goal weight.
GLP-1 drugs cause fat AND muscle loss. Sharpy leans on resistance training proven to protect lean mass — so the loss stays off.
A single number from 0–100 that grades how well you hit protein, hydration, movement, sleep, and strength training today.
Log your weight, watch the trend, and beat your Shape Score — without the calorie-counting theatrics.
Plain-English articles on side-effect management, protein targets, hydration, the maintenance phase, and life after the medication.
Your weight, meals, and workouts never leave your iPhone. No accounts, no ads, no data brokers — ever.
A single number from 0–100 that grades how well you hit the six factors that matter on a GLP-1 plan. No calorie counting. No food shame. Just a daily target you'll want to beat.
Plain-English guides for the GLP-1 generation — covering medication, diet, side-effect management, and the maintenance phase nobody plans for. 78+ articles.
A side-by-side comparison of the major GLP-1 medications: molecule, dosing, cost, FDA indication, side effects, and average weight loss. Pick the right one for your situation.
GLP-1 medications are not approved for pregnancy or breastfeeding. Here is the timing protocol, fertility implications, and what to know if you become pregnant unexpectedly.
GLP-1 medications reduce major cardiovascular events independently of weight loss. Here is what the SELECT trial showed and what it means for who should be on these drugs.
Binge eating disorder is the most common eating disorder, and GLP-1 medications often dramatically reduce binge episodes. Here is what to know — and the eating disorder cautions.
From "it just makes you sick" to "Ozempic causes cancer" — here are the most common GLP-1 myths and what the actual evidence says.
Non-alcoholic fatty liver disease (now called MASH) responds dramatically to GLP-1 medications. Here is the mechanism, the data, and what to expect.